CytoDyn Inc. (CYDY: OTCQB) | CytoDyn to Present New Data from Study of Investigational HIV Therapy Leronlimab (PRO 140), a Long-Acting, Single-Agent Maintenance Therapy at CROI 2019

OTC Markets Group – News, Filings & Corporate Actions

Pin It